Skip to main content

Lishomwa C Ndhlovu

NIH Rank #339
  • Program Leader
  • Top 5% Funded
  • R01 Holder
  • Multi-Institutional
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 9476960Search this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Internal Medicine
  • Pathology
  • VETERINARY SCIENCES
  • Microbiology & Immunology

NIH Funding · FY2026

Linked Award Amount
$7M
Full award amounts, FY2026
Award Records
6
Records listing this PI
Award-Linked Rank
#339
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Lishomwa C Ndhlovu. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing Lishomwa C Ndhlovu as a PI. Multi-PI records show the full award amount for context.

  • 5U01DA058527-04U01
    Elucidating single cell changes in neurogenic brain regions during HIV and cannabinoid exposure
    $2.3M
    award amount
  • 5R37AI189285-02R37
    Characterization of Allogeneic T Cells Mediating HIV Cure
    $1.6M
    award amount
  • 5R01MH130177-05R01
    Targeting CNS reservoirs with CAR/CXCR5 T cells for the long-term remission of HIV
    $893.5K
    award amount
  • 5R01AI184421-03R01
    Modulation of Galectin-9 to Target HIV Persistence
    $827.5K
    award amount
  • 5R01AI179324-04R01
    Defining the Immunogenicity and Efficacy of a Durable BCG Vaccine Strategy Optimized for Preventing TB in Pediatric HIV Infection
    $776.7K
    award amount
  • 5R01DA063076-02R01
    Single cell dark matter in the context of HIV and substance use
    $589.2K
    award amount

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Weill Cornell Medicine
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    $5M Cumulative Funding
  6. 2024
    $10M Cumulative Funding
  7. 2024
    Entered Top 50% Nationally
    Ranked #231
  8. 2024
    Entered Top 25% Nationally
    Ranked #231
  9. 2024
    Entered Top 10% Nationally
    Ranked #231
  10. 2024
    Entered Top 5% Nationally
    Ranked #231
  11. 2025
    $25M Cumulative Funding
  12. 2025
    Multi-Institutional Research
    Awards at 6 institutions
  13. 2025
    R01 Grant Holder
  14. 2025
    Program/Center Grant Leader